Bulk Manufacturer of Controlled Substances Application: Olon Ricerca Bioscience LLC

Download PDF
Federal RegisterJun 26, 2023
88 Fed. Reg. 41419 (Jun. 26, 2023)

AGENCY:

Drug Enforcement Administration, Justice.

ACTION:

Notice of application.

SUMMARY:

Olon Ricerca Bioscience LLC, has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

DATES:

Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before August 25, 2023. Such persons may also file a written request for a hearing on the application on or before August 25, 2023.

ADDRESSES:

The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 1301.33(a), this is notice that on May 17, 2023, Olon Ricerca Bioscience LLC, 7528 Auburn Road, Concord Township, Ohio 44077–9176 applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):

Controlled substance Drug code Schedule
Amphetamine 1100 II
Lisdexamfetamine 1205 II

The company plans to bulk manufacture the listed controlled substances for distribution to their customers. No other activities for these drug codes are authorized for this registration.

Matthew Strait,

Deputy Assistant Administrator.

[FR Doc. 2023–13471 Filed 6–23–23; 8:45 am]

BILLING CODE P